EPO Patents = 1

Forward Citations = 6

Loading Chart...

7 inventors (with patents filed for the assignee):

James Walter Janetka (5 out of 31 patents)

Katherine Louisa Widdowson (4 out of 6 patents)

Michael Joseph Bishop (4 out of 10 patents)

4. Eugene L Stewart (3 out of 4 patents)

5. Laurel Kathryn McGrane (2 out of 2 patents)

6. Laurel Kathryn Mcgrane (2 out of 2 patents)

7. Laurel Mydock-McGrane (1 out of 1 patent)

8. Vincent J Colandrea (1 patent)

9. Yuehu Li (0 patent)

10. Iulia Strambeanu (0 patent)

5 patents: Sort by Forward Citations

1. 12351597 - Substituted biphenyl or phenylheteroaryl-mannosides as antagonists of FimH (2025-07-08),

2. 12297223 - Compounds (2025-05-13),

3. 11697665 - C-mannoside compounds useful for the treatment of urinary tract infections (2023-07-11),

4. 11111262 - C-mannoside compounds useful for the treatment of urinary tract infections (2021-09-07),

5. 10738070 - Mannose-derived antagonists of FimH useful for treating disease (2020-08-11),

Fimbrion Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for patients with serious diseases. The company specializes in harnessing the power of its proprietary technology platform to create novel treatments that target unmet medical needs. With a commitment to advancing healthcare, Fimbrion aims to improve patient outcomes through its research and development efforts in various therapeutic areas.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

5 Patents

#267 in St. Louis, MO

#697 in Missouri

#50,255 in US

St. Louis, MO, United States of America

Fimbrion Therapeutics, Inc.